DK3810587T3 - Substituerede alkoxypyridinylindolsulfonamider - Google Patents

Substituerede alkoxypyridinylindolsulfonamider Download PDF

Info

Publication number
DK3810587T3
DK3810587T3 DK19731283.8T DK19731283T DK3810587T3 DK 3810587 T3 DK3810587 T3 DK 3810587T3 DK 19731283 T DK19731283 T DK 19731283T DK 3810587 T3 DK3810587 T3 DK 3810587T3
Authority
DK
Denmark
Prior art keywords
alkoxypyridinylindolesulfonamides
substituted
substituted alkoxypyridinylindolesulfonamides
Prior art date
Application number
DK19731283.8T
Other languages
English (en)
Inventor
Cécile Pegurier
Laurent Provins
Emre M Isin
Marie Ledecq
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Application granted granted Critical
Publication of DK3810587T3 publication Critical patent/DK3810587T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK19731283.8T 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider DK3810587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides
PCT/EP2019/066148 WO2019243398A1 (en) 2018-06-20 2019-06-19 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
DK3810587T3 true DK3810587T3 (da) 2022-10-31

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19731283.8T DK3810587T3 (da) 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider

Country Status (14)

Country Link
US (1) US11976056B2 (da)
EP (3) EP3584244A1 (da)
JP (1) JP7371031B2 (da)
CN (1) CN112292375B (da)
CA (1) CA3101086A1 (da)
DK (1) DK3810587T3 (da)
ES (1) ES2929829T3 (da)
HR (1) HRP20221289T1 (da)
HU (1) HUE060181T2 (da)
LT (1) LT3810587T (da)
MX (1) MX2020012823A (da)
PL (1) PL3810587T3 (da)
PT (1) PT3810587T (da)
WO (1) WO2019243398A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113993845A (zh) * 2019-06-17 2022-01-28 优时比制药有限公司 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物
JP2023531358A (ja) * 2020-05-01 2023-07-24 ザ チルドレンズ メディカル センター コーポレーション ミエリン形成を促進する組成物および方法
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
PL4298092T3 (pl) * 2021-02-26 2026-03-09 F. Hoffmann-La Roche Ag Nowe pochodne pirymidyn‑2‑ylosulfonamidu
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
CN119546572A (zh) * 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的萘基和异喹啉磺酰胺衍生物
WO2024017855A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
EP4558496A1 (en) * 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel pyrimidinyl and triazinyl sulfonamide derivatives
EP4558498A1 (en) 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives
CN119546576A (zh) 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的异喹啉酮、吡咯并吡啶酮和噻吩并吡啶酮磺酰胺衍生物
AR130023A1 (es) * 2022-07-28 2024-10-23 Hoffmann La Roche Derivados de indol sulfonamida 7 sustituidos
WO2024023129A1 (en) * 2022-07-28 2024-02-01 F. Hoffmann-La Roche Ag Novel 7-substituted indole sulfonamide derivatives
CA3262954A1 (en) * 2022-08-26 2024-02-29 F. Hoffmann-La Roche Ag NEW DEUTERED PYRIMIDINE-2-YL SULFONAMIDE DERIVATIVES
CN120641397A (zh) * 2022-12-02 2025-09-12 瑞文德医疗公众有限公司 稠合吡咯基磺酰胺化合物
WO2024153233A1 (en) * 2023-01-19 2024-07-25 Nanjing Immunophage Biotech Co., Ltd Compounds and their uses as gpr17 antagonists
GB2700773A (en) * 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds
GB2701173A (en) 2024-05-23 2026-04-22 Pheno Therapeutics Ltd Compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
EP1741792B1 (en) 2004-04-27 2010-11-03 Takeda Pharmaceutical Company Limited Novel ligand of g-protein-conjugated receptor protein and use thereof
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
EA200801369A1 (ru) 2005-12-20 2009-02-27 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы трансдермального введения агониста рецептора индолсеротонина и трансдермальные лекарственные формы для применения этого способа
WO2009000262A1 (de) 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
US20120172375A1 (en) * 2008-11-07 2012-07-05 Bruce Trapp Compounds and methods of promoting oligodendrocyte precursor differentiation
GB2491520A (en) 2010-03-11 2012-12-05 Jerry Swinford Method and apparatus for washing downhole tubulars and equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
EP2850068B1 (en) 2012-05-09 2019-05-29 Universita' degli Studi di Milano N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases
WO2018057989A1 (en) 2016-09-24 2018-03-29 Washington University INHIBITORS OF SARM1 NADase ACTIVITY AND USES THEREOF
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
PT3810587T (pt) 2022-11-14
PL3810587T3 (pl) 2023-02-06
JP7371031B2 (ja) 2023-10-30
LT3810587T (lt) 2022-11-25
CA3101086A1 (en) 2019-12-26
MX2020012823A (es) 2021-02-15
EP3810587A1 (en) 2021-04-28
WO2019243398A1 (en) 2019-12-26
HUE060181T2 (hu) 2023-02-28
JP2021527696A (ja) 2021-10-14
CN112292375A (zh) 2021-01-29
EP4086248A1 (en) 2022-11-09
HRP20221289T1 (hr) 2022-12-23
EP3584244A1 (en) 2019-12-25
US11976056B2 (en) 2024-05-07
US20210214337A1 (en) 2021-07-15
ES2929829T3 (es) 2022-12-01
EP3810587B1 (en) 2022-08-10
CN112292375B (zh) 2023-12-05

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
EP3890716A4 (en) COMBINATION THERAPIES
EP3801265B1 (en) URINARY FLOWMETER
EP3846674C0 (en) VAGINAL SPECULUM
EP3555124C0 (en) TCR NYESO
EP3849534A4 (en) COMBINATION THERAPIES
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
EP3878374A4 (en) Occlusion device
EP3721129C0 (en) Cryosphere
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem
EP3773733C0 (en) METALLO-LIOTHYRONINE
DK3752258T3 (da) Trampolin
EP3787554A4 (en) STENT TRANSPLANT
EP3738602A4 (en) CYTOCIDE
ES1207586Y (es) Furgo-caravana
EP3787995C0 (en) HARNESS SADDLE
MA49925A (fr) Claie
EP3767002A4 (en) PUNCH THORN